Galenica AG

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: CH0360674466
CHF
88.60
2.6 (3.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 11.84%

 
2

Flat results in Jun 25

 
3

With ROE of 13.37%, it has a Very Expensive valuation with a 3.08 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Retailing

stock-summary
Market cap

CHF 4,725 Million ()

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.43%

stock-summary
Debt Equity

0.51

stock-summary
Return on Equity

12.41%

stock-summary
Price to Book

3.19

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.25%
0%
8.25%
6 Months
17.82%
0%
17.82%
1 Year
19.41%
0%
19.41%
2 Years
24.0%
0%
24.0%
3 Years
22.04%
0%
22.04%
4 Years
37.36%
0%
37.36%
5 Years
33.13%
0%
33.13%

Galenica AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.51%
EBIT Growth (5y)
1.61%
EBIT to Interest (avg)
28.99
Debt to EBITDA (avg)
1.41
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
2.01
Tax Ratio
14.83%
Dividend Payout Ratio
68.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.84%
ROE (avg)
13.33%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
3.08
EV to EBIT
23.66
EV to EBITDA
15.51
EV to Capital Employed
2.46
EV to Sales
1.26
PEG Ratio
1.74
Dividend Yield
2.59%
ROCE (Latest)
10.39%
ROE (Latest)
13.37%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Galenica AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.67% vs 4.39% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.86% vs 5.34% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,921.10",
          "val2": "3,746.00",
          "chgp": "4.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "311.20",
          "val2": "288.30",
          "chgp": "7.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.10",
          "val2": "15.80",
          "chgp": "-17.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.60",
          "val2": "10.10",
          "chgp": "4.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "183.70",
          "val2": "165.70",
          "chgp": "10.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.40%",
          "val2": "49.50%",
          "chgp": "0.19%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
3,921.10
3,746.00
4.67%
Operating Profit (PBDIT) excl Other Income
311.20
288.30
7.94%
Interest
13.10
15.80
-17.09%
Exceptional Items
10.60
10.10
4.95%
Consolidate Net Profit
183.70
165.70
10.86%
Operating Profit Margin (Excl OI)
51.40%
49.50%
0.19%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 4.67% vs 4.39% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 10.86% vs 5.34% in Dec 2023

stock-summaryCompany CV
About Galenica AG stock-summary
stock-summary
Galenica AG
Retailing
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Company Coordinates stock-summary
Company Details
Untermattweg 8 , BERN None : 3027
stock-summary
Tel: 41 58 8528529
stock-summary
Registrar Details